United States · Series A startup

Who invested in Alphina Therapeutics

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$40Mraised across 2 rounds since 2021, from 2 sources

$40MSeries A$154KRound
Latest round
Round, $154KFeb 2026
Biggest round
$40MSeries A · Sept 2021
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20222023202420252026
$40MSeries A$154KRound
First round
Series A, $40M
Sept 2021
Biggest round
$40M
Series A · Sept 2021
Between rounds
4.5 years
from the last two

The rounds

  1. Feb 2026
    Round$154K

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $154K sold, first sale Feb 2026

  2. Sept 2021
    Series A$40M3 new

    Source recordedSEC filing: $17M sold, first sale Sept 2021

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

CanaanVC firm1round
Connecticut InnovationsGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Alphina Therapeutics

Who invested in Alphina Therapeutics?

Alphina Therapeutics's investors include Canaan, Connecticut Innovations and Alexandria Venture Investments.

How much has Alphina Therapeutics raised?

Alphina Therapeutics has raised $40M across 2 rounds since 2021.

When did Alphina Therapeutics last raise?

Alphina Therapeutics's most recent round, $154K, was in Feb 2026.

What was Alphina Therapeutics's biggest round?

Alphina Therapeutics's largest round on record is $40M (Series A), in Sept 2021.

Who backed Alphina Therapeutics first?

Alphina Therapeutics's first round on record, in Sept 2021, was backed by Canaan, Connecticut Innovations and Alexandria Venture Investments.

What stage is Alphina Therapeutics at?

Alphina Therapeutics's latest named round is a Series A, in Sept 2021.

Where is Alphina Therapeutics based?

Alphina Therapeutics is based in the United States.

Companies like Alphina Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.